Sale price$978.21

Special Order Item

Est. Delivery:
<p>Earn%20[points_amount]%20when%20completing%20this%20purchase.</p>

Description

APONVIE, SDV 32MG/4.4ML (10/CT)

Product Specs

Item Number 1271087
Catalog Number 47426040110
UOM CT
Level 1 Family Description Rx
Level 2 Category Description Rx-Specialty Rx
Level 3 Group Description Orange Specialty Rx
Level 4 Sub-Category Description Orange - Anti-Nausea
Application Neurokinin-1 Receptor Antagonist
Brand APONVIE
Buy American Act (BAA) Compliant No
Container Type Single-Dose Vial
Country of Origin Unknown
Dosage Form Injection
Generic Drug Code 52923
Generic Drug Name Aprepitant
Manufacturer Heron Therapeutics
Manufacturer # 47426040110
McKesson # 1271087
NDC Number 47426040110
Storage Requirements Requires Refrigeration
Strength 32 mg
Trade Agreement Act (TAA) Compliant No
Type Intravenous
UNSPSC Code 51294001
Volume 4.4 mL

Frequently asked questions

How is APONVIE administered?

APONVIE is formulated as an injectable emulsion designed exclusively for intravenous (IV) use in clinical environments.

Does this medication require special storage?

Yes, to maintain its integrity and shelf life, APONVIE must be kept under refrigeration at all times.

What is the primary use for this injection?

APONVIE is an NK1 receptor antagonist indicated as a single-dose medication to manage post-operative nausea and vomiting (PONV).

Is this a ready-to-use formulation?

Yes, it is provided in a ready-to-use single-dose vial (SDV) format, which helps streamline administration and reduces preparation time in surgical settings.

Is this product suitable for all facility types?

It is intended for hospital and surgical center pharmacy stock and must be administered by professionals following standard clinical protocols for anti-emetic therapy.

Are there any lead time requirements?

As this is a special order item, please plan for a 2-3 week lead time for delivery.

How many doses are included in a shipment?

Each unit includes 10 single-dose vials, with each vial containing 32 mg of aprepitant in a 4.4 mL volume.

What is the concentration of the medication?

Each vial contains 32 mg of aprepitant within a 4.4 mL total volume, resulting in a concentration of 7.2 mg/mL.

Does the vial design help prevent errors?

The vial is clearly labeled for “Intravenous Use Only” and is designed as a single-dose unit to support safe, single-patient administration practices.

Is this item compliant with TAA regulations?

No, this product is not Trade Agreement Act (TAA) compliant and is also not Buy American Act (BAA) compliant.